Analyst Ratings For NYSE:HAE – Haemonetics (NYSE:HAE)
Today, Jefferies Financial Group raised its price target on NYSE:HAE – Haemonetics (NYSE:HAE) to per share.
Some recent analyst ratings include
- 2/7/2018-JMP Securities Reiterated Rating of Outperform.
- 1/2/2018-Raymond James Upgrade from a “Underperform ➝ Market Perform” rating to a “” rating.
- 11/8/2017-Craig Hallum Reiterated Rating of Hold.
- 11/7/2016-BTIG Research Reiterated Rating of Neutral.
Recent Insider Trading Activity For NYSE:HAE – Haemonetics (NYSE:HAE)
NYSE:HAE – Haemonetics (NYSE:HAE) has insider ownership of 1.20% and institutional ownership of 99.34%.
- On 6/7/2018 Christopher Simon, CEO, sold 1,941 with an average share price of $92.73 per share and the total transaction amounting to $179,988.93.
- On 6/7/2018 Dan Goldstein, VP, sold 3,794 with an average share price of $95.09 per share and the total transaction amounting to $360,771.46.
- On 6/7/2018 Jacqueline Scanlan, SVP, sold 214 with an average share price of $92.73 per share and the total transaction amounting to $19,844.22.
- On 6/7/2018 Michelle L. Basil, EVP, sold 457 with an average share price of $92.73 per share and the total transaction amounting to $42,377.61.
- On 6/7/2018 William P. Mr. Burke, CFO, sold 425 with an average share price of $92.73 per share and the total transaction amounting to $39,410.25.
- On 4/6/2018 Dan Goldstein, VP, sold 518 with an average share price of $54.65 per share and the total transaction amounting to $28,308.70.
- On 3/6/2018 Jacqueline Scanlan, SVP, sold 114 with an average share price of $72.23 per share and the total transaction amounting to $8,234.22.
Recent Trading Activity for NYSE:HAE – Haemonetics (NYSE:HAE)
Shares of NYSE:HAE – Haemonetics closed the previous trading session at 95.30 up +3.54 3.86% with 95.31999969482422 shares trading hands.